Idiopathic pulmonary hemosiderosis

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis
Status:
Not yet recruiting
Last Changed:
Dec 7, 2016
First Changed:
Dec 7, 2016
Disease(s):
Idiopathic Pulmonary Hemosiderosis
Intervention(s):
Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis
PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood
Status:
Unknown status
Last Changed:
Nov 8, 2012
First Changed:
Apr 4, 2008
Disease(s):
Central Alveolar Hypoventilation Syndrome
Intervention(s):
CPAP

Connect. Empower. Inspire.